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Introduction 
Sarcopenia, the loss of skeletal muscle mass and strength that occurs with advancing age [1] is 
correlated with functional decline and disability but little is known about its relationship with 
cardiovascular risk.  Bioimpedence analysis (BIA) is a validated technique for measuring muscle mass, 
convenient for use in large cohort studies. Arterial stiffness (compliance) is an independent predictor 
of cardiovascular events.   
Methods 
The BRAVES study was designed to compare cardiovascular risk between two healthy elderly cohorts 
in the UK and in Italy. We used data from the UK cohort to investigate the relationship between 
sarcopenia and vascular compliance.  
Participants were eligible if aged 65-85 years, lived within the Brighton area and had weight loss of 
no more than 5% in the last month. All underwent physical exam, BIA assessment of skeletal mass 
index (SMI) and two measures of arterial compliance.  Pulse wave velocity (PWV) was measured 
between carotid-femoral and carotid-radial arteries and the augmentation index (AIx) derived from 
carotid and radial arteries. A bivariate correlation was performed.  
Results 
Ninety patients (64 female; 26 male) had mean age 73, mean FFM 46.84kg (range 34.7-74.7) and 
mean SMI 6.77 (range 4.84-10.09). There was a negative relationship between SMI and Radial AIx 
(R=0.-542, p=0.000) as well as Carotid AIx (R=-0.391, p=0.002) but not PWV. Using multiple 
regression to control for the effects of age and gender, SMI was independently related to radial AIx 
(p=.013). 
Conclusions 
Skeletal muscle mass index is strongly negatively correlated with augmentation index, a measure of 
vascular stiffness. This finding suggests that elderly patients with higher muscle mass have a more 
compliant aorta and hence lower cardiovascular risk. Whether sarcopenia acts as a marker for CV 
risk or plays an active role in cardiovascular disease progression is not yet established and deserves 
further investigation.    
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